198 related articles for article (PubMed ID: 10390013)
41. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.
Li Q; Dong X; Gu W; Qiu X; Wang E
Chin Med J (Engl); 2003 May; 116(5):727-30. PubMed ID: 12875690
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
45. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
46. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma].
Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP
Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645
[TBL] [Abstract][Full Text] [Related]
47. [Relation of vascular endothelial growth factor-D expression to microvessel density, microlymphatic vessel density, and lymph-node metastasis of lung adenocarcinoma].
Cong B; Zhao X; Zhao XG; Dong XP; Peng CL
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2179-82. PubMed ID: 19080666
[TBL] [Abstract][Full Text] [Related]
48. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
49. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
[TBL] [Abstract][Full Text] [Related]
51. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
[TBL] [Abstract][Full Text] [Related]
52. [Expression of vascular endothelial growth factor C in laryngeal squamous carcinoma and its role in lymphatic metastasis].
Wang ZL; Chen Y; Zhou B; Liang CY; Zhang L; Li RX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):47-9. PubMed ID: 14981813
[TBL] [Abstract][Full Text] [Related]
53. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Tsukiyama A; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Mod Pathol; 2003 Apr; 16(4):309-14. PubMed ID: 12692195
[TBL] [Abstract][Full Text] [Related]
55. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
56. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
[TBL] [Abstract][Full Text] [Related]
57. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
58. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis.
Guo X; Chen L; Lang R; Fan Y; Zhang X; Fu L
Am J Clin Pathol; 2006 Nov; 126(5):740-6. PubMed ID: 17050071
[TBL] [Abstract][Full Text] [Related]
59. [Correlation of lymphangiogenesis to progression of colorectal cancer].
Wang TB; Huang YH; Lan P; Song XM; Wang JP
Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
[TBL] [Abstract][Full Text] [Related]
60. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
